A cohort study in 2012, which characterised the contribution of rare CNVs in the risk of CHD, identified twelve patients with 15q11.2 deletions, at a frequency of 0.53%, as compared to only one individual with BP1-BP2 deletion in the healthy control cohort. Here, IGFBP2 is linked to coronary artery disorder.